Infectious Disease Firm GeneWeave Raises $12M in Series A Financing Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Infectious disease technology firm GeneWeave Biosciences announced it has raised $12 million in a Series A financing round.

Decheng Capital led the round, joined by existing investors Claremont Creek Ventures and X/Seed Capital. The funds will be used to complete the development, validation, and clearance of the initial test for a platform being developed for detecting infectious diseases, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.